Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001209191-22-050881

Chief Scientific Officer returned 1,413 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Beskrovnaya Oxana Chief Scientific Officer 2022-09-20 Returned to the company −1,413 $13.70 $19,358 50,825 D
Loading xslF345X03/doc4.xml…